National Peroxide last traded at ₹590.15 (2026-10-13). Over the past month the stock moved -5.1%, three months the stock moved -1.8%, year the stock moved -2.5%. Its closing range over 52 weeks is ₹368.40 – ₹674.75, with the latest close 12.5% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1954, National Peroxide Ltd is a manufacturer of Hydrogen Peroxide[1]
Business Overview:[1] NPL is a part of the Wadia Group which holds 70.8% in the company. NPL manufactures peroxygen chemicals and is the largest producer of hydrogen peroxide in India
In the latest quarter (Jun 2026), National Peroxide reported sales of ₹96.07 crore (+44.1%) and net profit of ₹6.61 crore (+642.7%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 96.07 | 12.23 | 12.73 | 6.61 | 11.50 |
| Mar 2026 | 85.68 | 14.88 | 17.37 | 9.23 | 16.06 |
| Dec 2025 | 69.09 | 6.99 | 10.12 | 1.83 | 3.18 |
| Sep 2025 | 68.29 | 4.50 | 6.59 | 0.39 | 0.68 |
| Jun 2025 | 66.66 | 4.82 | 7.23 | 0.89 | 1.55 |
| Mar 2025 | 73.70 | -2.35 | -3.19 | -6.49 | -11.29 |
| Dec 2024 | 62.16 | 3.23 | 5.20 | -1.52 | -2.64 |
| Sep 2024 | 77.02 | 4.12 | 5.35 | 0.68 | 1.18 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -5.8% | -25.7% | -16.3% | -9.9% | -11.3% | +11.1% | +16.3% | +44.1% |
| Operating profit growth | -54.4% | -65.7% | -126.0% | -52.8% | +9.2% | +116.4% | – | +153.7% |
| Net profit growth | -84.7% | -131.9% | -311.4% | -82.5% | -42.6% | – | – | +642.7% |
| EPS growth | -84.7% | -131.8% | -311.4% | -82.5% | -42.4% | – | – | +641.9% |
| OPM % | 5.4% | 5.2% | -3.2% | 7.2% | 6.6% | 10.1% | 17.4% | 12.7% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), National Peroxide reported sales of ₹290.00 crore (+1.0%) and net profit of ₹11.00 crore, compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 290.00 | 31.00 | 11.00 | 11.00 | 19.21 |
| Mar 2025 | 287.00 | 15.00 | 5.00 | -2.00 | – |
| Mar 2024 | 333.00 | 38.00 | 11.00 | 17.00 | – |
| Mar 2023 | 377.00 | 60.00 | 16.00 | 40.00 | – |
| Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|
| Sales growth | -11.7% | -13.8% | +1.0% |
| Operating profit growth | -36.7% | -60.5% | +106.7% |
| Net profit growth | -57.5% | -111.8% | – |
| EPS growth | – | – | – |
| OPM % | 11.0% | 5.0% | 11.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for National Peroxide.
Get Free AI Stock Analysis FREE →National Peroxide appoints Vinay Divakar Jayade as CEO and WTD - scanx.trade
National Peroxide appoints Vinay Divakar Jayade as CEO and WTD - scanx.trade
National Peroxide standalone net profit rises 642.70% in the June 2026 quarter - business-standard.com
National Peroxide Limited Reports Mixed Financial Performance for Q4 FY26 - scanx.trade
National Peroxide Limited Reports Mixed Financial Performance for Q4 FY26 - scanx.trade
National Peroxide Limited Reports Mixed Financial Performance for Q4 FY26 - scanx.trade
National Peroxide Limited Reports Mixed Financial Performance for Q4 FY26 - scanx.trade
National Peroxide Limited Reports Mixed Financial Performance for Q4 FY26 - scanx.trade
National Peroxide Limited Reports Mixed Financial Performance for Q4 FY26 - scanx.trade
National Peroxide shares were last quoted at ₹590.15 (+0.3% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
National Peroxide has a price-to-earnings (P/E) ratio of 20.54 and a price-to-book (P/B) ratio of 0.93. The industry P/E is 54.21.
The 52-week high of National Peroxide is ₹708.45 and the 52-week low is ₹350.00.
The market capitalisation of National Peroxide is about ₹344.19 crore.
In the latest quarter (Jun 2026), National Peroxide reported sales of ₹96.07 crore (+44.1%) and net profit of ₹6.61 crore (+642.7%), compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, National Peroxide has a 3-year ROE of 2.00%, 3-year profit growth of -41.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 70.77% of National Peroxide.
National Peroxide belongs to the Chemicals sector.